FDA Warning Letter — Park Infusioncare LP
The FDA took a Warning Letter action against Park Infusioncare LP on Mar 1, 2018 (Dallas, TX). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action details
- Facility
- Park Infusioncare LP
- Date
- Mar 1, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Center
- CDER
- Location
- Dallas, TX (United States)